Abstract:The Nipah virus (NiV), a zoonotic virus in the Henipavirus genus of the Paramyxoviridae family, emerged in Malaysia in 1998 and later spread globally. Diseased patients may have a 40- 70% chance of fatality depending on the severity and early medication. The recent outbreak of NiV was reported in Kerala (India) by a new strain of MCL-19-H-1134 isolate. Currently, no vaccines are available, highlighting the critical need for a conclusive remedy. Our study aims to develop a subunit vaccine against the NiV by analyzing its proteome. NiV genome and proteome sequences were obtained from the NCBI database. A phylogenetic tree was constructed based on genome alignment. T-cell, helper T-cell, and B-cell epitopes were predicted from the protein sequences using NetCTL-1.2, NetMHCIIPan-4.1, and IEDB servers, respectively. High-affinity epitopes for human receptors were selected to construct a multi-epitope vaccine (MEV). These epitopes' antigenicity, toxicity, and allergenicity were evaluated using VaxiJen, AllergenFP-v.1.0, and AllergenFP algorithms. Molecular interactions with specific receptors were analyzed using PyRx and ClusPro. Amino acid interactions were visualized and analyzed using PyMOL and LigPlot. Immuno-simulation was conducted using C-ImmSim to assess the immune response elicited by the MEV. Finally, the vaccine cDNA was inserted into the pET28a(+) expression vector using SnapGene tool for in silico cloning in an E. coli host. The potential for an imminent outbreak cannot be overlooked. A subunit vaccine is more cost-effective and time-efficient. With additional in vitro and in vivo validation, this vaccine could become a superior preventive measure against NiV disease. Supplementary information: The online version contains supplementary material available at 10.1007/s40203-024-00246-9.

Development of Fusion-Based Assay as a Drug Screening Platform for Nipah Virus Utilizing Baculovirus Expression Vector System

Optimization of Bangladesh and Malaysian genotype recombinant reporter Nipah viruses for in vitro antiviral screening and in vivo disease modeling

Crystal Structure of the Pre-Fusion Nipah Virus Fusion Glycoprotein Reveals A Novel Hexamer-Of-Trimers Assembly

Establishment of a novel minigenome system for the identification of drugs targeting Nipah virus replication

From antibiotic to antiviral: computational screening reveals a multi-targeting antibiotic from Streptomyces spp. against Nipah virus fusion proteins

Streamlined detection of Nipah virus antibodies using a split NanoLuc biosensor

Establishment of a neutralization assay for Nipah virus using a high-titer pseudovirus system

Reverse Vaccinology Analysis of B-cell Epitope against Nipah Virus using Fusion Protein

Development of a novel real-time polymerase chain reaction assay for the quantitative detection of Nipah virus replicative viral RNA

Are we ready to fight the Nipah virus pandemic? An overview of drug targets, current medications, and potential leads

Revolutionizing Nipah virus vaccinology: insights into subunit vaccine development strategies and immunological advances

Protracted molecular dynamics and secondary structure introspection to identify dual-target inhibitors of Nipah virus exerting approved small molecules repurposing

In silico Identification of Potential Small Molecules Targeting Six Proteins in Nipah Virus using Molecular Docking, Pharmacophore and Molecular Dynamics Simulation

Nipah Virus: A Multidimensional Update

Cell-free expression of Nipah virus transmembrane proteins for proteoliposome vaccine design

Novel methods for the rapid and sensitive detection of Nipah virus based on CRISPR/Cas12a system

Inactivated Recombinant Rabies Virus Displaying the Nipah Virus Envelope Glycoproteins Induces Systemic Immune Responses in Mice

Fully human single-domain antibody targeting a highly conserved cryptic epitope on the Nipah virus G protein

Interaction of Nipah Virus F and G with the Cellular Protein Cortactin Discovered by a Proximity Interactome Assay

Development and laboratory evaluation of a competitive ELISA for serodiagnosis of Nipah and Hendra virus infection using recombinant Nipah glycoproteins and a monoclonal antibody

Exploration of Flavonoids to identify Potential Therapeutic Compounds by Targeting the Non-Structural V protein of Nipah Virus